RxDoctor Payments Data

Donna-Marie Manasseh, MD

Surgery · Washington, DCNPI 1942209580

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,931 of the $3,438 with a category attached, or 85.3%. 11 manufacturers reported payments, led by Axogen at 48.8% of the total. Reporting peaked in 2023 at $1,682 and has fallen 88.4% since, to $196 in 2025.

$3,438in general payments, 2019–2025

Across 23 payments — averaging $149.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axogen$2K
  • Pacira Pharmaceuticals Incorporated$483
  • Molli Surgical (US) Inc$387
  • Focal Therapeutics, Inc.$203
  • Hologic Inc$188
  • Dilon Technologies, Inc.$184
  • plus $315 from 5 others

What the payments were for

  • Travel & lodging$50715%
  • Food & beverage$2,93185%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Axogen9$1,679
Pacira Pharmaceuticals Incorporated1$483
Molli Surgical (US) Inc1$387
Focal Therapeutics, Inc.1$203
Hologic Inc2$188
Dilon Technologies, Inc.1$184
Endomagnetics Ltd1$117
Leica Microsystems Inc.1$66
KUB Technologies Inc.2$64
Vertex3$54
Gilead1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,438 in reported general payments places this provider in the 60th percentile of 117 surgery providers in District of Columbia.

See all surgery providers in District of Columbia

Medicare billing

Part B allowed, 2024
$41,732
Medicare patients
115
Services billed
202

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →